Transcriptional modulation of foreign gene expression in engineered somatic tissues

Cell Biology and Toxicology

Volumn 14, Issue 2, 1998, Pages 83-94

  Bohl, D ^a   Heard, J M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Gene therapy; Regulation; Transcription

Indexed keywords

4 HYDROXYTAMOXIFEN; CD34 ANTIGEN; DNA; DOXYCYCLINE; INTERFERON; RAPAMYCIN; RETINOID X RECEPTOR; STEROID RECEPTOR; TACROLIMUS; TETRACYCLINE; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN; VIRUS VECTOR;

CONFERENCE PAPER; DNA BINDING; DNA SEQUENCE; GENE; GENE EXPRESSION; GENE THERAPY; HORMONE RESPONSIVE ELEMENT; HUMAN; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC ENGINEERING; HUMANS; POLYENES; RECEPTORS, STEROID; REPRESSOR PROTEINS; SIROLIMUS; TETRACYCLINE; TETRACYCLINE RESISTANCE; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 0031892632     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007480419685     Document Type: Conference Paper

References (85)

1. Ackland-Berglund CE, Leib DA. Efficacy of tetracycline-controlled gene expression is influenced by cell type. BioTechniques. 1995;18:196-200.
2. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoint and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA. 1995;92:8493-7.
3. Baulieu E-E. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science. 1989;245:1351-7.
4. Blanchard KL, Acquaviva AM, Galson DL, Bunn FH. Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor elements. Mol Cell Biol. 1992; 12: 5373-85.
5. Blau CA, Peterson KR, Drachman JG, Spencer DM. A proliferation switch for genetically modified cells. Proc Natl Acad Sci USA. 1997;94:3076-81.
6. Bohl D, Heard JM. Modulation of erythropoietin delivery from engineered muscles in mice. Hum Gene Ther. 1997;8:195-204.
7. Bohl D, Naffakh N, Heard JM. Long term control of erythropoietin secretion levels by tetracycline in mice transplanted with engineered primary myoblasts. Nature Med. 1997;3:299-312.
8. Braselmann S, Graninger P, Busslinger M. A selective transcriptional induction system for mammalian cells based on GAL4-estrogen receptor fusion protein. Proc Natl Acad Sci USA. 1993;90:1657-61.
9. Cao J, Park I, Cooper A, Sodroski J. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J Virol. 1996;70:1340-54.
10. Cayrol C, Flemington EK. Identification of cellular target genes of the Epstein-Barr virus transactivator Zta activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1. J Virol. 1995;69:206-12.
11. Christopherson KS, Mark MR, Bajaj V, Godowski PJ. Ecdysteroid-dependent regulation of genes in mammalian cells by a Drosophila ecdysone receptor and chimeric transactivators. Proc Natl Acad Sci USA. 1992;89:6314-8.
12. Cox LA, Adrian GS. Posttranscriptional regulation of chimeric human transferrin genes by iron. Biochemistry. 1993;32: 4738-45.
13. Dauvois S, White R, Parker MG The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci. 1993; 106:1377-88.
14. Davis JL, Gross PR, Danos O. Development and characterization of a translationally regulated retroviral vector. Abstract, Keystone Meeting, April 13-19; 1997.
15. Degenkolb J, Takahashi M, Ellestad GA, Hillen W. Structural requirements of tetracycline-tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the tet repressor. Antimicrob Agents Chemother. 1991;35:1591-5.
16. Delort JP, Capecchi MR. TAXI/UAS: a molecular switch to control expression of genes in vivo. Hum Gene Ther. 1996;7:809-20.
17. Deuschle U, Meyer WK-H, Thiesen H-J. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol. 1995; 15: 1907-14.
18. Dingermann T, Frank-Stoll U, Werner H et al. RNA polymerase III catalysed transcription can be regulated in Saccharomyces cerevisiae by the bacterial tetracycline repressor-operator system. EMBO J. 1992a;11:1487-92.
19. Dingermann T, Werner H, Schütz A et al. Establishment of a system for conditional gene expression using an inducible tRNA suppressor gene. Mol Cell Biol. 1992b;12:4038-45.
20. Efrat S, Fusco-DeMane D, Lemberg H, Al Emran O, Wang X. Conditional transformation of a pancreatic b-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA. 1995;92: 3576-80.
21. Emerman M, Temin HM. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 1984;39:459-67.
22. Feil R, Brocard J, Mascrez B, Le Meur M, Metzger D, Chambon P. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA. 1996;93:10887-90.
23. Fishman GI, Kaplan ML, Buttrick PM. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest. 1994;93:1864-8.
24. Freiberg RA, Spencer DM, Choate KA et al. Specific triggering of the fas signal transduction pathway in normal human keratinocytes. J Biol Chem. 1996;27:31666-9.
25. Freiberg RA, Ho SN, Khavari PA. Transcriptional control in keratinocytes and fibroblasts using synthetic ligands. J Clin Invest. 1997;99:2610-5.
26. Furth PA, St Onge L, Böger H et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA. 1994;91:9302-6.
27. Gatz C, Kaiser A, Wendenburg R. Regulation of a modified CaMV 35A promoter by the Tn10-encoded Tet repressor in transgenic tabacco. Mol Gen Genet. 1991;27:229-37.
28. Godowski PJ, Picard D, Yamamoto KR. Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins. Science. 1988;241:812-6.
29. Goossen B, Wright Caughman S, Harford JB, Klausner RD, Hentze MW. Translational repression by a complex between the iron-responsive element of ferritin mRNA and its specific cytoplasmic binding protein is position dependent in vivo. EMBO J. 1990;9:4127-33.
30. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA. 1992;89:5547-51.
31. Gossen M, Bujard H. Anhydrotetracycline, a novel effector for tetracycline controlled gene expression in eukaryotic cells. Nucleic Acids Res. 1993;21:4411-2.
32. Gossen M, Freundlieb S, Bender G, Müller G, Killen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995;268:1766-9.
33. Green S, Chambon P. Oestradiol induction of a glucocorticoidresponsive gene by a chimeric receptor. Nature. 1987;325: 75-8.
34. Guo H, Kohlhaw B. Regulation of transcription in mammalian cells by yeast Leu3p and externally supplied inducer. FEBS. 1996;390:191-5.
35. Hofman A, Nolan G, Blau HB. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 1996;93:5185-90.
36. Hoshimaru M, Ray J, Sah DWY, Gage FH. Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci USA 1996;93:1518-23.
37. Howe JR, Skryabin BV, Belcher SM, Zerillo CA, Schmauss C. The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem. 1995;270:14168-78.
38. A promoter. Mol Cell Biol. 1990;10:6141-151.
39. Hwang JJ, Scuric Z, Anderson WF. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracyclineresponsive expression system. J Virol. 1996;70:8138-41.
40. Iida A, Chen ST, Friedmann T, Yee JK. Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J Virol. 1996;70:6054-9.
41. Ingles CJ, Shales M, Cress WD, Triezenberg SJ, Greenblatt J. Reduced binding of TFIID to transcriptionally compromised mutants of VP16. Nature. 1991;351:588-90.
42. Israel D, Kaufman RJ. Highly inducible expression from vectors containing multiple GRE's in CHO cells overexpressing the glucocorticoid receptor. Nucleic Acids Res. 1989; 17:4589-604.
43. Jiang B, Rue E, Wang GL, Roe R, Semenza GI. Dimerization, DNA binding and transactivation properties of hypoxiainducible factor 1. J Biol Chem. 1996;271:17771-8.
44. Kenan DJ, Tasi DE, Keene JD. Exploring molecular diversity with combinational shape libraries. TIBS. 1994;19:57-64.
45. Kim HJ, Gatz C, Hillen W, Jones TR. Tetracycline repressorregulated gene repression in recombinant human cytomegalovirus. J Virol. 1995;69:2565-73.
46. Ko MSH, Takahashi N, Sugiyama N, Takano T. An auto-inducible vector conferring high glucocorticoid inducibility upon stable transformant cells. Genes. 1989;84:383-9.
47. Liberles SD, Diver ST, Austin DJ, Schreiber SL. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc Natl Acad Sci USA. 1997;94:7825-30.
48. Lin Y-S, Ha I, Maldonado E, Reinberg D, Green MR. Binding of general transcription factors TFIIB to an acidic activating region. Nature. 1991;353:569-71.
49. Madan A, Curtin PT. A 24-base-pair sequence 3́ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc Natl Acad Sci USA. 1993;90: 3928-32.
50. Mader S, White JS. A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells. Proc Natl Acad Sci USA. 1993;90:5603-7.
51. Mahfoudi A, Roulet E, Dauvois S, Parker MG, Whali W Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc Natl Acad Sci USA. 1995;92:4206-10.
52. Marsolier MC, Chaussivert N, Lefebvre O, Conesa C, Werner M, Sentenac A. Directing transcription of an RNA polymerase III gene via GAL4 sites. Proc Natl Acad Sci USA. 1994;91:11938-42.
53. Maxwell I, Spitzer A, Long C, Maxwell F. Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters. Gene Ther. 1996;3:28-36.
54. Mayo KE, Warren R, Palmiter RD. The mouse metallothionein-I gene is transcriptionally regulated by cadmium following transfection into human or mouse cells. Cell. 1982;29:99-108.
55. Miller K, Rizzino A. The function of inducible promoter systems in F9 embryonal carcinoma cells. Exp Cell Res. 1995;218:144-50.
56. Neering SJ, Hardy SF, Minamoto D, Spratt SK, Jordan CT. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood. 1996;88:1147-55.
57. No D, Yao T, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA. 1996;93:3346-51.
58. Ornitz DM, Moreadith RW, Leder P. Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc Natl Acad Sci USA. 1991;88:698-702.
59. Passman RS, Fishman GI. Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest. 1994;94:2421-5.
60. Paulus W, Baur I, Boyce FM, Breakefield XO, Reeves SA. Self-contained, tetracycline-regulated retroviral system for gene delivery to mammalian cells. J Virol. 1996;70:62-7.
61. Resnitzky D, Hengst L, Reed SI. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell Biol. 1995;15:4347-52.
62. Rivera VM, Clackson T, Natesan S et al. A humanized system for pharmacologic control of gene expression. Nature Med. 1996;2:1028-32.
63. Röder FT, Schmülling T, Gatz C. Efficiency of the tetracyclinedependent gene expression system: complete suppression and efficient induction of the rolB phenotype in transgenic plants. Mol Gen Genet. 1994;243:32-8.
64. Schaack J, Guo X, Ho Y, Karlok M, Chen C, Oernelles D. Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines. J Virol. 1995;69:4079-85.
65. Schultze N, Burki Y, Lang Y, Certa U, Bluethmann H. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nature Biotech. 1996;14:499-505.
66. Schweinfest CW, Jorcyk CL, Fujiwara S, Papas TS. A heat-shock inducible eukaryotic expression vector. Gene. 1988;71:207-10.
67. Searl PF, Stuart GW, Palmiter RD. Building a metal-responsive promoter with synthetic regulatory elements. Mol Cell Biol. 1985;5:1480-9.
68. Shan B, Lee W Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol. 1994;14:8166-73.
69. Shockett P, Difilippantonio M, Hellman N, Schatz D. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA. 1995;92:6522-6.
70. Spencer DM, Belshaw PJ, Chen L et al. Functional analysis of fas signaling in vivo using synthetic inducers of dimerization. Curr Biol. 1996;6:839-47.
71. Staeheli P, Danielson P, Haller O, Sutcliffe JG. Transcriptional activation of the mouse Mx gene by type 1 interferon. Mol Cell Biol. 1986;6:4770-4.
72. Thomas HE, Stunnenberg HG, Stewart AF. Heterodimerization of the Drosophila ecdysone receptor with retinoid X receptor and ultraspirale. Nature. 1993;362:471-5.
73. Totzke F, Marmé D, Hug R. Inducible expression of human phospholipase C-g2 and its activation by platelet-derived growth factor B-chain homodimer and platelet-derived growth factor A-chain homodimer in transfected NIH 3T3. Eur J Biochem. 1992;203:633-9.
74. Triezenberg SJ, Kingsbury RC, McKnight SL. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev. 1988;2: 718-29.
75. Wang GL, Semenza GL. General involvement of hypoxiainducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA. 1993;90:4304-8.
76. Wang Y, O'Malley BW Jr, Tasai SY, O'Malley BW A regulatory system for use in gene transfer. Proc Natl Acad Sci USA. 1994;91:8180-4.
77. G is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 transactivator. 1988a;52:169-78.
78. Webster NJG, Green S, Jin JR, Chambon P. The hormonebinding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. 1988b;54:199-207.
79. Wimmel A, Lucibello FC, Sewing A, Adolph S, Muller R. Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene. 1994;9:995-7.
80. Wirtz E, Clayton C. Inducible gene expression in trypanosomes mediated by a prokaryotic repressor. Science. 1995;268: 1179-83.
81. Wurm FM, Gwinn KA, Kingston RE. Inducible overexpression of a mouse c-myc protein in mammalian cells. Proc Natl Acad Sci USA. 1986;83:5414-8.
82. Xu L, Yee JK, Wolff JA, Friedmann T. Factors influencing long-term stability of Moloney leukemia virus-based vectors. Virology. 1989;171:331-41.
83. Yao TP, Forman BM, Jiang Z et al. Functional ecdysone receptor is the product of EcR and ultraspiracle genes. Nature. 1993;366:476-9.
84. Yao YP, Segraves WA, Oro AE, McKeown M, Evans RM. Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation. Cell. 1992;71:63-72.
85. Yarraton GT. Inducible vectors for expression in mammalian cells. Curr Opin Biotech. 1992;3:506-11.